Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs Dexamethasone for Carpal Tunnel Syndrome Hydrodissection
NCT04527770Completed
- Sponsor
- Minia University
- Start
- Sep 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of midazolam in carpal tunnel syndrome (CTS), sponsored by Minia University. Primary endpoint: Efficacy of midazolam against dexamethasone at 6 months. Started Sep 2020; status: completed.
02
Drugs
midazolam
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT04527770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04527770.